Mobile Health Messaging for HIV/AIDS
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a mobile health messaging system (Mobile Health Messaging application) designed to help women with HIV adhere to their treatment plans. The system sends reminders about appointments, prescriptions, and medication, and addresses challenges such as stigma or mistrust of the medical system. Participants will either receive standard care or additional support through this messaging system and patient navigation. Women who have faced issues like missed appointments or detectable viral loads (amount of HIV in the blood) may be well-suited for the trial. As an unphased trial, this study offers participants the chance to contribute to innovative solutions that could enhance adherence to HIV treatment plans.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It seems focused on helping you stick to your existing HIV treatment plan.
What prior data suggests that this mobile health messaging application is safe for use in HIV care?
Research has shown that mobile health messages, like those in this study, are generally safe. Studies have found that mobile reminders can help people with HIV adhere better to their treatment plans. For example, one study found that these messages helped patients take their medication on time more often. Another study showed that the messages helped patients keep up with their appointments and prescriptions.
No reports indicate harmful side effects from using mobile health messages. These messages are designed to remind and support, not to act as medication or physical treatment. Participants usually handle them well. If considering joining this trial, there is no evidence suggesting any safety concerns from using the mobile health messaging system itself.12345Why are researchers excited about this trial?
Researchers are excited about the Mobile Health Messaging treatment for HIV/AIDS because it offers a new way to support patients through digital engagement. Unlike standard treatments that primarily focus on medications like antiretrovirals, this approach uses a mobile health application to deliver psycho-educational messages, providing ongoing support and education right at a patient’s fingertips. This method could improve patient adherence to medication and overall health outcomes by offering personalized, real-time guidance and navigation assistance, making it a unique complement to traditional care.
What evidence suggests that the Mobile Health Messaging application could be effective for HIV care?
Research has shown that mobile health tools, such as text message reminders, can help people with HIV adhere to their antiretroviral therapy (ART) medication schedule. In this trial, participants in the Mobile Health Messaging Arm will receive standard care, patient navigation assistance, and the mobile health intervention, which includes psycho-educational messaging. One study found that SMS reminders improved medication adherence among HIV patients. A review of several studies also found that text messages significantly helped young people with HIV adhere to their ART regimen. Additionally, these mobile health tools can enhance the overall well-being of people living with HIV by addressing challenges like stigma and distrust in medical care, making them a valuable component of HIV treatment.678910
Who Is on the Research Team?
Lunthita M Duthely, Ed.D.
Principal Investigator
University of Miami
Are You a Good Fit for This Trial?
This trial is for women over 18 with HIV who have missed appointments, had a detectable viral load, or haven't taken their meds as prescribed. They must be currently in care or recently back in care and own a working cell phone. It's not for men, those under 18, cognitively impaired individuals unable to consent, or without a cell phone.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Participants receive mobile health messaging and patient navigation to improve treatment adherence and address barriers to HIV care
Follow-up
Participants are monitored for changes in clinic attendance, stigma, medical mistrust, and resilience
What Are the Treatments Tested in This Trial?
Interventions
- Mobile Health Messaging application
- Standard of Care Treatment
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Miami
Lead Sponsor
National Institute on Drug Abuse (NIDA)
Collaborator